METTL14 deletion led to the accumulation of BPTF, and the BPTF super-enhancer promoted pulmonary metastasis of RCC by increasing the expression of the glycolytic reprogramming proteins ENO2 and SRC [106]. The gene discussed is METTL14; the disease is renal cell carcinoma.